Key questions for perioperative chemotherapy in resectable lung cancer: not pre vs post, but who and what? [electronic resource]
Producer: 20090804Description: 527, 532 p. digitalISSN:- 0890-9091
- Antigens, Neoplasm -- immunology
- Cancer Vaccines
- Carcinoma, Non-Small-Cell Lung -- mortality
- Chemotherapy, Adjuvant
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Humans
- Lung Neoplasms -- mortality
- Neoadjuvant Therapy
- Neoplasm Proteins -- immunology
- Patient Selection
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Randomized Controlled Trials as Topic
No physical items for this record
Publication Type: Journal Article; Comment
There are no comments on this title.
Log in to your account to post a comment.